These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 29610286)

  • 1. Immunotherapy for Pancreatic Cancer: More Than Just a Gut Feeling.
    Riquelme E; Maitra A; McAllister F
    Cancer Discov; 2018 Apr; 8(4):386-388. PubMed ID: 29610286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression.
    Pushalkar S; Hundeyin M; Daley D; Zambirinis CP; Kurz E; Mishra A; Mohan N; Aykut B; Usyk M; Torres LE; Werba G; Zhang K; Guo Y; Li Q; Akkad N; Lall S; Wadowski B; Gutierrez J; Kochen Rossi JA; Herzog JW; Diskin B; Torres-Hernandez A; Leinwand J; Wang W; Taunk PS; Savadkar S; Janal M; Saxena A; Li X; Cohen D; Sartor RB; Saxena D; Miller G
    Cancer Discov; 2018 Apr; 8(4):403-416. PubMed ID: 29567829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of the Microbiome in Immunologic Development and its Implication For Pancreatic Cancer Immunotherapy.
    Sethi V; Vitiello GA; Saxena D; Miller G; Dudeja V
    Gastroenterology; 2019 May; 156(7):2097-2115.e2. PubMed ID: 30768986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the immune landscape and tumor microenvironment of pancreatic cancer to improve immunotherapy.
    Torphy RJ; Schulick RD; Zhu Y
    Mol Carcinog; 2020 Jul; 59(7):775-782. PubMed ID: 32166821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dilemma and Challenge of Immunotherapy for Pancreatic Cancer.
    Wu J; Cai J
    Dig Dis Sci; 2021 Feb; 66(2):359-368. PubMed ID: 32140943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of pancreatic cancer.
    Sunami Y; Kleeff J
    Prog Mol Biol Transl Sci; 2019; 164():189-216. PubMed ID: 31383405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging trends in the immunotherapy of pancreatic cancer.
    Banerjee K; Kumar S; Ross KA; Gautam S; Poelaert B; Nasser MW; Aithal A; Bhatia R; Wannemuehler MJ; Narasimhan B; Solheim JC; Batra SK; Jain M
    Cancer Lett; 2018 Mar; 417():35-46. PubMed ID: 29242097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral CpG-B Promotes Antitumoral Neutrophil, cDC, and T-cell Cooperation without Reprograming Tolerogenic pDC.
    Humbert M; Guery L; Brighouse D; Lemeille S; Hugues S
    Cancer Res; 2018 Jun; 78(12):3280-3292. PubMed ID: 29588348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The microbiome and hepatobiliary-pancreatic cancers.
    Mima K; Nakagawa S; Sawayama H; Ishimoto T; Imai K; Iwatsuki M; Hashimoto D; Baba Y; Yamashita YI; Yoshida N; Chikamoto A; Baba H
    Cancer Lett; 2017 Aug; 402():9-15. PubMed ID: 28527946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral Bacteria as Mediators of Cancer Immunotherapy Response.
    Sfanos KS
    Cancer Res; 2023 Sep; 83(18):2985-2986. PubMed ID: 37712178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harnessing the Microbiome for Pancreatic Cancer Immunotherapy.
    Vitiello GA; Cohen DJ; Miller G
    Trends Cancer; 2019 Nov; 5(11):670-676. PubMed ID: 31735286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex Role of Microbiome in Pancreatic Tumorigenesis: Potential Therapeutic Implications.
    Amara S; Yang LV; Tiriveedhi V; Muzaffar M
    Cells; 2022 Jun; 11(12):. PubMed ID: 35741028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice.
    Smith JP; Wang S; Nadella S; Jablonski SA; Weiner LM
    Cancer Immunol Immunother; 2018 Feb; 67(2):195-207. PubMed ID: 29043413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the intratumoral microbiome on tumor occurrence, progression, prognosis and treatment.
    Gao F; Yu B; Rao B; Sun Y; Yu J; Wang D; Cui G; Ren Z
    Front Immunol; 2022; 13():1051987. PubMed ID: 36466871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response.
    Sethi V; Kurtom S; Tarique M; Lavania S; Malchiodi Z; Hellmund L; Zhang L; Sharma U; Giri B; Garg B; Ferrantella A; Vickers SM; Banerjee S; Dawra R; Roy S; Ramakrishnan S; Saluja A; Dudeja V
    Gastroenterology; 2018 Jul; 155(1):33-37.e6. PubMed ID: 29630898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer.
    Mohammed S; Sukumaran S; Bajgain P; Watanabe N; Heslop HE; Rooney CM; Brenner MK; Fisher WE; Leen AM; Vera JF
    Mol Ther; 2017 Jan; 25(1):249-258. PubMed ID: 28129119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Gut Microbiome and Pancreatic Cancer Development and Treatment.
    Attebury H; Daley D
    Cancer J; 2023 Mar-Apr 01; 29(2):49-56. PubMed ID: 36957973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of 2-arachidonoylglycerol in the regulation of the tumor-immune microenvironment in murine models of pancreatic cancer.
    Qiu C; Yang L; Wang B; Cui L; Li C; Zhuo Y; Zhang L; Zhang S; Zhang Q; Wang X
    Biomed Pharmacother; 2019 Jul; 115():108952. PubMed ID: 31078044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation of the tumour microenvironment by a CD40 agonist antibody correlates with improved responses to PD-L1 blockade in a mouse orthotopic pancreatic tumour model.
    Luheshi NM; Coates-Ulrichsen J; Harper J; Mullins S; Sulikowski MG; Martin P; Brown L; Lewis A; Davies G; Morrow M; Wilkinson RW
    Oncotarget; 2016 Apr; 7(14):18508-20. PubMed ID: 26918344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraepithelial Attack Rather than Intratumorally Infiltration of CD8+T Lymphocytes is a Favorable Prognostic Indicator in Pancreatic Ductal Adenocarcinoma.
    Zhang J; Wang YF; Wu B; Zhong ZX; Wang KX; Yang LQ; Wang YQ; Li YQ; Gao J; Li ZS
    Curr Mol Med; 2017; 17(10):689-698. PubMed ID: 29521231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.